GlassScriptPhysician profile
Richard Leader
NPI 1619914330
$489.46
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $145 · 2021: $70.95 · 2022: $23.01.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $122.36 | 2019 | |
| Dysis Medical, INC. | $65.90 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.87 | 2020 | |
| Allergan, INC. | $28.94 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $27.94 | 2019 | |
| Pfizer INC. | $27.11 | 2019-2020 | |
| Covidien LP | $24.61 | 2019 | |
| Ethicon US, LLC | $23.99 | 2021 | |
| Intuitive Surgical, INC. | $23.01 | 2022 | |
| Astellas Pharma US INC | $17.90 | 2021 | |
| Millicent US INC | $16.41 | 2019 | |
| Boston Scientific Corporation | $16.20 | 2019 | |
| Abbvie INC. | $16.16 | 2021 | |
| Avion Pharmaceuticals | $13.44 | 2020 | |
| Evofem Biosciences, INC. | $12.90 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $12.72 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Leader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.